StemCells, Inc. Completes Enrollment in Spinal Cord Injury Trial By: Benzinga via Benzinga April 17, 2014 at 08:02 AM EDT StemCells, Inc. (Nasdaq: STEM) announced today that it has completed enrollment in the Company's Phase I/II clinical trial in spinal ... Read More >>